1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rociletinib in NSCLC patients with negative central testing for T790M in TIGER-X
    Meeting Abstract

    Wakelee, H. A.; Sequist, L. V.; Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Yu, H.; Camidge, D. R.; Solomon, B. J.; Matheny, S.; Despain, D.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Oncogenic drivers including RET and ROS1 plus PTEN loss and MET by IHC in patients with lung adenocarcinomas: Lung Cancer Mutation Consortium 2.0
    Meeting Abstract

    Johnson, B. E.; Kris, M. G.; Wistuba, I. I.; Berry, L.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B.; Otterson, G.; Schiller, J.; Cetnar, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Dose optimization of rociletinib for EGFR mutated NSCLC
    Meeting Abstract

    Goldman, J. W.; Wakelee, H. A.; Gadgeel, S.; Camidge, D. R.; Solomon, B. J.; Yu, H.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; Perol, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy of pembrolizumab in key subgroups of patients with advanced NSCLC
    Meeting Abstract

    Hellmann, M. D.; Garon, E. B.; Gandhi, L.; Hui, R.; Zhang, J.; Rangwala, R.; Lubiniecki, G.; Rizvi, N. A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Pembrolizumab 2 mg/kg Q3W for previously treated, PD-L1-positive advanced NSCLC
    Meeting Abstract

    Fløtten, Ø.; Garon, E. B.; Arkenau, H. T.; Hui, R.; Gandhi, L.; Felip, E.; Lena, H.; Cappuzzo, F.; Horn, L.; Gubens, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
    Meeting Abstract

    Poirier, J.; Gardner, E.; Connis, N.; Moreira, A.; De Stanchina, E.; Hann, C.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Updated efficacy/safety data from the phase 2 NP28761 study of alectinib in ALK plus NSCLC
    Meeting Abstract

    Shaw, A.; West, H.; Socinski, M. A.; Ou, I.; Gandhi, L.; Gadgeel, S.; Belani, C. P.; Shirai, K.; Bazhenova, L.; Santos, E.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Pembrolizumab for NSCLC: Immune-mediated adverse events and corticosteroid use
    Meeting Abstract

    Leighl, N.; Gandhi, L.; Hellmann, M. D.; Horn, L.; Ahn, M. J.; Garon, E. B.; Hui, R.; Ramalingam, S. S.; Zhang, J.; Lubiniecki, G.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of PD-L1 expression in metachronous tumor samples and FDG-PET as a predictive biomarker in Ph2 study (FIR) of atezolizumab (MPDL3280A)
    Meeting Abstract

    Chaft, J. E.; Chao, B.; Akerley, W. L.; Gordon, M.; Antonia, S. J.; Callahan, J.; Sandler, A.; Funke, R.; Li, Z.; Fredrickson, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save